Zepp Health Corporation (ZEPP)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNY m | 932 | 969 | 616 | 353 | 1,333 | 1,815 | 1,927 | 2,190 |
| Operating profit | CNY m | -205 | -240 | ||||||
| Net profit | CNY m | 33 | 21 | -43 | -31 | -554 | -281 | -301 | -0 |
| EPS reported | CNY | -283.0 | -292.8 | ||||||
| Operating cashflow per share | CNY | -180.8 | -181.1 | ||||||
| Capex per share | CNY | 5.52 | 5.53 | ||||||
| FCF per share | CNY | -186.3 | -186.6 | ||||||
| Free cash flow | CNY m | -185 | -185 | ||||||
| Net debt | CNY m | 797 | 948 | ||||||
| Book value equity | CNY m | 1,500 | 1,256 | ||||||
| Book value per share | CNY | 1,509 | 1,269 | ||||||
| Number of shares | m | 0.99 | 0.99 | ||||||
| DPS (TTM paid) | CNY | 0.00 | 0.00 |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 0.02 | 0.02 | ||||||
| P/S LTM | x | 0.01 | 0.01 | ||||||
| P/FCF LTM | x | -0.14 | -0.14 | ||||||
| EV/EBITDA LTM | x | -4.34 | -3.31 | ||||||
| EV/Sales LTM | x | 0.46 | 0.74 | ||||||
| Earnings Yield LTM | % | -10.49% | -8.36% | ||||||
| FCF Yield | % | -691.45% | -691.45% | ||||||
| Quality | |||||||||
| ROE | % | -18.73% | -23.93% | ||||||
| ROIC | % | -6.58% | -6.64% | ||||||
| Operating margin | % | -11.29% | -10.39% | ||||||
| Gross margin | % | +39.20% | +38.69% | ||||||
| FCF/Sales | % | -10.20% | -9.64% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +36.12% | +44.52% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -0.12 | -0.11 | ||||||
| Net Debt/EBITDA | x | -4.20 | -4.61 | ||||||
| EBIT/Net interest | x | -5.13 | -4.72 | ||||||
| Net debt/market cap | % | +59.27% | +3.39% | ||||||
| Net debt/Equity | x | 0.53 | 0.76 | ||||||
| Gross debt/equity | x | 1.06 | 1.33 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices. Operating predominantly within the People's Republic of China, the company divides its operations into two main segments: Xiaomi Wearable Products and its own-branded products and other ventures. Its diverse product range includes smart bands, watches, and scales, in addition to hearable devices, home fitness equipment like treadmills, sportswear, selected home appliances, and various smartwatch accessories. These offerings are marketed under both the Xiaomi and Amazfit brands. Zepp Health also empowers users with detailed analyses of their collected activity and biometric data, presented through intuitive charts and graphs accessible via its proprietary Zepp Life and Zepp mobile applications.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices. Operating predominantly within the People's Republic of China, the company divides its operations into two main segments: Xiaomi Wearable Products and its own-branded products and other ventures. Its diverse product range includes smart bands, watches, and scales, in addition to hearable devices, home fitness equipment like treadmills, sportswear, selected home appliances, and various smartwatch accessories. These offerings are marketed under both the Xiaomi and Amazfit brands. Zepp Health also empowers users with detailed analyses of their collected activity and biometric data, presented through intuitive charts and graphs accessible via its proprietary Zepp Life and Zepp mobile applications.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free